| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.043 | 0.4 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.048 | 0.4 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.4 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.4 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |